Dengue Virus Infection of Primary Endothelial Cells Induces Innate Immune Responses, Changes in Endothelial Cells Function and Is Restricted by Interferon-Stimulated Responses

Journal of Interferon and Cytokine Research

Volumn 35, Issue 8, 2015, Pages 654-665

  Calvert, Julie K ^a   Helbig, Karla J ^b   Dimasi, David ^c   Cockshell, Michaelia ^c   Beard, Michael R ^b,c   Pitson, Stuart M ^c   Bonder, Claudine S ^c   Carr, Jillian M ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BLOCKING ANTIBODY; SHORT HAIRPIN RNA; SPHINGOSINE KINASE 1; STAT1 PROTEIN; INTERFERON; PROTEIN; RSAD2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CELL FUNCTION; COLONY FORMING CELL; CONFOCAL MICROSCOPY; DENGUE; DENGUE VIRUS 2; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA EXTRACTION; WESTERN BLOTTING; DENGUE VIRUS; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TIME FACTOR; UMBILICAL VEIN ENDOTHELIAL CELL; VIROLOGY; VIRUS REPLICATION;

DENGUE VIRUS;

DENGUE VIRUS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INTERFERONS; PHOSPHORYLATION; PROTEINS; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSFECTION; VIRUS REPLICATION;

EID: 84938864135     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0195     Document Type: Article

References (68)

1. AbuBakar S, Shu MH, Johari J, Wong PF. 2014. Senescence affects endothelial cells susceptibility to dengue virus infection. Int J Med Sci 11(6):538-544.
2. Anderson R, Wang S, Osiowy C, Issekutz AC. 1997. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 71(6):4226-4232.
3. Andrews BS, Theofilopoulos AN, Peters CJ, Loskutoff DJ, Brandt WE, Dixon FJ. 1978. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect Immun 20(3):776-781.
4. Appleby SL, Cockshell MP, Pippal JB, Thompson EJ, Barrett JM, Tooley K, Sen S, Sun WY, Grose R, Nicholson I, Levina V, Cooke I, Talbo G, Lopez AF, Bonder CS. 2012. Characterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3. PLoS One 7(11): e46996.
5. Arevalo MT, Simpson-Haidaris PJ, Kou Z, Schlesinger JJ, Jin X. 2009. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J Med Virol 81(3):519-528.
6. Artpradit C, Robinson LN, Gavrilov BK, Rurak TT, Ruchirawat M, Sasisekharan R. 2013. Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles. Virus Res 176(1-2):69-77.
7. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161(11):6338-6346.
8. Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, Kasinrerk W, Malasit P, Atkinson JP, Diamond MS. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog 3(11):e183.
9. Baccala R, Welch MJ, Gonzalez-Quintial R, Walsh KB, Teijaro JR, Nguyen A, Ng CT, Sullivan BM, Zarpellon A, Ruggeri ZM, de la Torre JC, Theofilopoulos AN, Oldstone MB. 2014. Type I interferon is a therapeutic target for virus-induced lethal vascular damage. Proc Natl Acad Sci U S A 111(24): 8925-8930.
10. Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, Beatty PR, Harris E. 2009. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 80(3):416-424.
11. Barrett JM, Parham KA, Pippal JB, Cockshell MP, Moretti PA, Brice SL, Pitson SM, Bonder CS. 2011. Over-expression of sphingosine kinase-1 enhances a progenitor phenotype in human endothelial cells. Microcirculation 18(7):583-597.
12. Basu A, Chaturvedi UC. 2008. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol 53(3):287-299.
13. Basu A, Jain P, Sarkar P, Gangodkar S, Deshpande D, Ganti K, Shetty S, Ghosh K. 2011. Dengue virus infection of SK Hep1 cells: inhibition of in vitro angiogenesis and altered cytomorphology by expressed viral envelope glycoprotein. FEMS Immunol Med Microbiol 62(2):140-147.
14. Bonder CS, Sun WY, Matthews T, Cassano C, Li X, Ramshaw HS, Pitson SM, Lopez AF, Coates PT, Proia RL, Vadas MA, Gamble JR. 2009. Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation. Blood 113(9): 2108-2117.
15. Bunyaratvej A, Butthep P, Yoksan S, Bhamarapravati N. 1997. Dengue viruses induce cell proliferation and morphological changes of endothelial cells. Southeast Asian J Trop Med Public Health 28 Suppl 3:32-37.
16. Cardier JE, Marino E, Romano E, Taylor P, Liprandi F, Bosch N, Rothman AL. 2005. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 30(6):359-365.
17. Carr JM, Hocking H, Bunting K, Wright PJ, Davidson A, Gamble J, Burrell CJ, Li P. 2003. Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. J Med Virol 69(4): 521-528.
18. Carr JM, Kua T, Clarke JN, Calvert JK, Zebol JR, Beard MR, Pitson SM. 2013. Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA. J Gen Virol 94(Pt 11):2437-2448.
19. Celis A, Moros Z, Gerder M, Pagano F, Vizzi E, Liprandi F. 2014. [Selection of heparin-sensitive dengue virus variants in BHK-21 cells]. Invest Clin 55(2):155-167 (Article in Spanish).
20. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. 2007. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virusinduced hemorrhage. J Virol 81(11):5518-5526.
21. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8):866-871.
22. Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ, Stark GR. 2013. IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J 32(20):2751-2763.
23. da Conceicao TM, Rust NM, Berbel AC, Martins NB, do Nascimento Santos CA, Da Poian AT, de Arruda LB. 2013. Essential role of RIG-I in the activation of endothelial cells by dengue virus. Virology 435(2):281-292.
24. Dalrymple N, Mackow ER. 2011. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol 85(18): 9478-9485.
25. Dalrymple NA, Mackow ER. 2012a. Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol 86(12):6408-6415.
26. Dalrymple NA, Mackow ER. 2012b. Roles for endothelial cells in dengue virus infection. Adv Virol 2012:840654.
27. Dalrymple NA, Mackow ER. 2014. Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Curr Opin Virol 7C:134-140.
28. Dewi BE, Takasaki T, Kurane I. 2004. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121(2): 171-180.
29. Dewi BE, Takasaki T, Kurane I. 2008. Peripheral blood mononuclear cells increase the permeability of dengue virusinfected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol 89(Pt 3):642-652.
30. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. 2000a. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74(17):7814-7823.
31. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. 2000b. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74(11):4957-4966.
32. Gamble JR, Sun WY, Li X, Hahn CN, Pitson SM, Vadas MA, Bonder CS. 2009. Sphingosine kinase-1 associates with integrin {alpha}V{beta}3 to mediate endothelial cell survival. Am J Pathol 175(5):2217-2225.
33. Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW, Zarski JP, Drouet E. 2002. Heparan sulfatemediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292(1):162-168.
34. Gualano RC, Pryor MJ, Cauchi MR, Wright PJ, Davidson AD. 1998. Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. J Gen Virol 79(Pt 3):437-446.
35. Helbig KJ, Carr JM, Calvert JK, Wati S, Clarke JN, Eyre NS, Narayana SK, Fiches GN, McCartney EM, Beard MR. 2013. Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis 7(4):e2178.
36. Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, McCartney EM, Jangra RK, Lemon SM, Beard MR. 2011. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 54(5):1506-1517.
37. Hilgard P, Stockert R. 2000. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 32(5):1069-1077.
38. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63(1-2): 71-75.
39. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. 2004. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104(9):2752-2760.
40. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189(8):1411-1418.
41. Lee E, Wright PJ, Davidson A, Lobigs M. 2006. Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. J Gen Virol 87(Pt 10):2791-2801.
42. Li X, Stankovic M, Bonder CS, Hahn CN, Parsons M, Pitson SM, Xia P, Proia RL, Vadas MA, Gamble JR. 2008. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood 111(7):3489-3497.
43. Limaye V, Xia P, Hahn C, Smith M, Vadas MA, Pitson SM, Gamble JR. 2009. Chronic increases in sphingosine kinase- 1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cell Mol Biol Lett 14(3):424-441.
44. Lin YL, Lei HY, Lin YS, Yeh TM, Chen SH, Liu HS. 2002. Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res 56(1):93-96.
45. Litwin M, Clark K, Noack L, Furze J, Berndt M, Albelda S, Vadas M, Gamble J. 1997. Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J Cell Biol 139(1):219-228.
46. Liu P, Woda M, Ennis FA, Libraty DH. 2009. Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. J Infect Dis 200(2):191-201.
47. Machesky NJ, Zhang G, Raghavan B, Zimmerman P, Kelly SL, Merrill AH, Jr., Waldman WJ, Van Brocklyn JR, Trgovcich J. 2008. Human cytomegalovirus regulates bioactive sphingolipids. J Biol Chem 283(38):26148-26160.
48. Martina BE, Koraka P, Osterhaus AD. 2009. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22(4): 564-581.
49. Monick MM, Cameron K, Powers LS, Butler NS, McCoy D, Mallampalli RK, Hunninghake GW. 2004. Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus. Am J Respir Cell Mol Biol 30(6):844-852.
50. Oldstone MB. 2013. Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza. Proc Natl Acad Sci U S A 110(11):4180-4183.
51. Peyrefitte CN, Pastorino B, Grau GE, Lou J, Tolou H, Couissinier-Paris P. 2006. Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes. J Med Virol 78(2):229-242.
52. Pitman MR, Pham DH, Pitson SM. 2012. Isoform-selective assays for sphingosine kinase activity. Methods Mol Biol 874:21-31.
53. Povoa TF, Alves AM, Oliveira CA, Nuovo GJ, Chagas VL, Paes MV. 2014. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One 9(4):e83386.
54. Raekiansyah M, Espada-Murao LA, Okamoto K, Kubo T, Morita K. 2014. Dengue virus neither directly mediates hyperpermeability nor enhances tumor necrosis factor-alphainduced permeability in vitro. Jpn J Infect Dis 67(2):86-94.
55. Safronetz D, Prescott J, Feldmann F, Haddock E, Rosenke R, Okumura A, Brining D, Dahlstrom E, Porcella SF, Ebihara H, Scott DP, Hjelle B, Feldmann H. 2014. Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques. Proc Natl Acad Sci U S A 111(19):7114-7119.
56. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to Image J: 25 years of image analysis. Nat Methods 9(7):671-675.
57. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, Garcia-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505(7485):691-695.
58. Seo YJ, Alexander S, Hahm B. 2011. Does cytokine signaling link sphingolipid metabolism to host defense and immunity against virus infections? Cytokine Growth Factor Rev 22(1): 55-61.
59. Spiropoulou CF, Srikiatkhachorn A. 2013. The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome. Virulence 4(6):525-536.
60. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. 2004. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85(Pt 7):1801-1813.
61. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, Martinborough E, Peach R, Oldstone MB, Rosen H. 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146(6): 980-991.
62. Trung DT, Wills B. 2010. Systemic vascular leakage associated with dengue infections-the clinical perspective. Curr Top Microbiol Immunol 338:57-66.
63. Vervaeke P, Alen M, Noppen S, Schols D, Oreste P, Liekens S. 2013. Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III. PLoS One 8(8):e74035.
64. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I. 2003. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 77(21):11822-11832.
65. Wati S, Rawlinson SM, Ivanov RA, Dorstyn L, Beard MR, Jans DA, Pitson SM, Burrell CJ, Li P, Carr JM. 2011. Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-alpha to activate nuclear factor kappaB and reduced sphingosine kinase-1 activity. J Gen Virol 92(Pt 4):807-818.
66. Yen YT, Chen HC, Lin YD, Shieh CC, Wu-Hsieh BA. 2008. Enhancement by tumor necrosis factor alpha of dengue virusinduced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol 82(24):12312-12324.
67. Zamudio-Meza H, Castillo-Alvarez A, Gonzalez-Bonilla C, Meza I. 2009. Cross-talk between Rac1 and Cdc42 GTPases regulates formation of filopodia required for dengue virus type-2 entry into HMEC-1 cells. J Gen Virol 90(Pt 12):2902-2911.
68. Zellweger RM, Prestwood TR, Shresta S. 2010. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7(2):128-139.